C0670896||Toll-like Receptors
C1384660||NLRP3
C2936529||inflammasome
C3887595||autophagosomes
C3887595||DRibbles
C3887595||Autophagosomes
C0597032||tumor cells
C3887595||defective ribosomal products
C0005758||blebs
C3887595||DRibbles
C0039194||T-cell
C0007613||responses
C0376659||cancer vaccines
C1516211||cancer models
C0684224||report
C3887595||DRibbles
C1155065||T-cell activation
C3887595||DRibbles
C1326120||activated
C0003315||antigen-presenting cells
C0003315||antigen-presenting cells
C3887595||DRibbles
C0007589||differentiation
C0026473||monocytes
C0003315||DC precursor (pre-DC) cells
C0003315||antigen-presenting cells
C3887595||DRibbles
C1514762||innate receptor signaling
C0754728||Toll-like Receptors (TLR)-2
C1411976||TLR4
C1579758||TLR7
C1579755||TLR8
C2698508||nucleotide-binding oligomerization domain-containing protein 2
C2698508||nucleotide-binding oligomerization domain-containing protein 2
C1534866||TLR3
C0966553||TLR5
C0963057||TLR9
C3887595||DRibbles
C1321301||PBMCs
C0079189||pro-inflammatory cytokines
C0021760||IL-6
C0085295||IL-10
C1456820||TNF-α
C0021753||IL-1β
C3887595||DRibbles
C0021753||IL-1β
C1321301||PBMC
C0682523||THP-1 cells
C0023810||LPS
C0444669||core
C3156614||NLRP3 inflammasomes
C0014139||endocytosis
C3272080||inflammasome activation
C1257986||cross presentation
C0034850||endosome
C1522821||acidification
C4235027||ER-associated degradation (ERAD) pathway
C3887595||DRibbles
C1564907||pattern recognition receptors
C3887595||DRibbles
C0003320||antigen
C1155229||adaptive immune responses
C0597032||tumor cells
C0042776||viruses
C0007613||inhibitory effect
C0004391||autophagy
C3272080||inflammasome activation
C0003315||antigen-presenting cells
C2603343||study
C3887595||autophagosomes
C3887595||DRibbles
C0003320||antigen
C0007634||donor cells
C3272080||activate inflammasomes
C0021753||IL-1β
C1321301||PMBC